Company intelligence / Profile preview

Medicon Hellas

Ownership: Private
Development stage: Commercial

Overview

Medicon Hellas offers a wide range of diagnostic instruments and reagents for clinical laboratories and hospitals. The company has an established R&D program focused on developing new diagnostic products to improve efficiency and quality in medical testing. It also operates a fully automated diagnostic laboratory using its own in-vitro diagnostic products. The company’s products are certified to international standards including ISO13485/ISO9001 and CE marking.

Therapeutic areas: Other
Modalities: Diagnostic deviceSoftware (for laboratory/medical applications)Reagent (clinical chemistry, hematology, immunochemistry)Point-of-care system
Industry: Protein Biomarker Diagnostics

Partnerships

OEM partners for reagent export; no major pharma/biotech partnerships disclosed.

Beyond the preview

Go deeper on Medicon Hellas.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medicon Hellas.

Explore the full profile